Dewave Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 165.50%
- Profit Growth 93.15%
- Ebitda 93.15%
- Net Worth 235.25%
- Total Assets 23.37%
About Dewave Life Sciences
Dewave Life Sciences Private Limited (DLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 July 2019 (Five years and six months 18 days old ). Its registered office is in Bhubaneswar, Orissa, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Debashish Dash and Padmanav Mohapatra serve as directors at the Company.
Company Details
-
Location
Bhubaneswar, Orissa, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24305OR2019PTC031379
-
Company No.
031379
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Jul 2019
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Dewave Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Debashish Dash
|
Managing Director | 25-Jul-2019 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Padmanav Mohapatra
|
Director | 25-Jul-2019 | Current |
Financial Performance of Dewave Life Sciences.
Dewave Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 165.5% increase. The company also saw a substantial improvement in profitability, with a 93.15% increase in profit. The company's net worth Soared by an impressive increase of 235.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dewave Life Sciences?
In 2023, Dewave Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dewave Life Sciences?
Unlock and access historical data on people associated with Dewave Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dewave Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dewave Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.